Ad Header



The Pulse of the Pharmaceutical Industry

Judge dismisses two Express Scripts claims

Written by: | | Dated: Friday, March 24th, 2017


Judge dismisses two Express Scripts claims in Anthem drug pricing lawsuit



A federal judge has dismissed two of the six counterclaims that pharmacy benefits manager Express Scripts Holding Co raised in health insurer’s Anthem Inc’s $15 billion lawsuit claiming it charged too much for drugs.

In a decision made public on Friday, U.S. District Judge Edgardo Ramos in Manhattan dismissed Express Scripts’ claim that Anthem breached an implied covenant of good faith and fair dealing, saying it duplicated a breach of contract claim. He also dismissed an unjust enrichment claim.

Anthem had sued Express Scripts last March, accusing it of excessive pricing and operational failures. It also sought the right to terminate its 10-year contract with Express Scripts, which began in 2009.


(Reporting by Jonathan Stempel in New York)


Reuters source:

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!


Ad Right Bottom